Merifin Capital

Total investments

13

Average round size

27M

Portfolio companies

9

Follow on index

0.31

Exits

3

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
BiotechnologyHealth CareGeneticsManufacturingMedicalPharmaceuticalTherapeuticsSemiconductorShoppingPrinting

Summary

The fund was located in Europe if to be more exact in Belgium. The main department of described VC is located in the Bel.

Among the most popular portfolio startups of the fund, we may highlight Plastic Logic Germany, F2G, Flayr. The fund has specific favorite in a number of founders of portfolio startups. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Biotechnology, Medical.

The top activity for fund was in 2014. The increased amount of exits for fund were in 2007. This Merifin Capital works on 12 percentage points less the average amount of lead investments comparing to the other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually.

Besides them, we counted 5 critical employees of this fund in our database.

The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Merifin Capital, startups are often financed by Principia SGR, Astellas Venture Management, Amadeus Capital Partners. The meaningful sponsors for the fund in investment in the same round are 360 Capital Partners, Sunstone Life Science Ventures, Quest for Growth. In the next rounds fund is usually obtained by Wellington Partners, 360 Capital Partners, dievini Hopp Biotech Holding.

Show more

Investments analytics

Analytics

Total investments
13
Lead investments
0
Exits
3
Follow on index
0.31
Investments by industry
  • Biotechnology (7)
  • Pharmaceutical (5)
  • Medical (5)
  • Health Care (4)
  • Genetics (4)
  • Show 12 more
Investments by region
  • United Kingdom (5)
  • Germany (2)
  • United States (3)
  • Italy (2)
  • France (1)
Peak activity year
2004

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
20
Avg. valuation at time of investment
3M
Group Appearance index
1.00
Avg. company exit year
6
Avg. multiplicator
5.04

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
DanioLabs 17 Jan 2005 Biotechnology, Therapeutics Early Stage Venture 4M Cambridge, United Kingdom, England

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.